Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' (Deficiency) Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Shareholders' (Deficiency) Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 132,411 $ (122,754) $ 9,657
Beginning balance, shares at Dec. 31, 2021 2,416,021      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs of $111 3,005 3,005
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 298,761      
Share based compensation 521 521
Net loss (4,811) (4,811)
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units, shares 13,721      
Issuance of common stock for board of directors’ compensation 235 235
Issuance of common stock for board of directors' compensation, shares 24,458      
Ending balance, value at Mar. 31, 2022 136,172 (127,565) 8,607
Ending balance, shares at Mar. 31, 2022 2,752,961      
Beginning balance, value at Dec. 31, 2022 144,328 (141,351) 2,977
Beginning balance, shares at Dec. 31, 2022 4,659,769      
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs of $111 102 102
Issuance of common shares pursuant to at-the-market registered offering, net of issuance costs, shares 119,104      
Share based compensation 222 222
Net loss (4,386) (4,386)
Ending balance, value at Mar. 31, 2023 $ 144,652 $ (145,737) $ (1,085)
Ending balance, shares at Mar. 31, 2023 4,778,873